Revealing the Hidden Threat: Three innovative strategies for assessing disease burden today, tomorrow, and beyond
As the frequency, scale, and impact of infectious disease outbreaks continue to increase, the pharmaceutical industry faces significant challenges in assessing emerging needs and opportunities due to under diagnoses and underreporting. These data gaps hinder our ability to accurately determine the true burden of diseases and respond effectively. Access a free copy of BlueDot’s new eBook to uncover three innovative strategies for assessing disease burden today, tomorrow and beyond.